Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

Share Price is delayed by 15 minutes
Get Live Data
15.50    0.00 (0.00%)
Bid:
14.10
Ask:
16.90
Spread: 2.80 (19.858%)
Market Cap: £12.51m
LMS Live PriceLast checked at - London Stock Exchange

Intraday Lms Capital Share Chart

First Quarter 2021 Update

29 Apr 2021 07:00

RNS Number : 9899W
LMS Capital PLC
29 April 2021
 

 

 

 

 

 

 

 

29 April 2021

 

 

LMS CAPITAL PLC

First Quarter 2021 Update

 

LMS Capital plc (the "Company") the listed investment company provides the following update covering the period from 1 January 2021 to date.

 

Financial Highlights

 

· Unaudited Net Asset Value ("NAV") at 31 March 2021 was £47.5 million (58.9p per share). This compares to £47.9 million (59.4p per share) at 31 December 2020; and

· Cash at 31 March 2021 was £21.5 million compared to £20.6 million at 31 December 2020 and increased due to £1.6 million of portfolio distributions.

 

Unaudited Net Asset Value at 31 March 2021

 

The £0.4 million decrease in NAV during the first quarter arises from £0.3 million of unrealised gains on the investment portfolio, offset by £0.2 million of portfolio foreign exchange losses from the weakening of the U.S. Dollar against the sterling and £0.5 million of running costs and investment costs.

 

NAV at 31 March 2021 is summarised below:

 

Unaudited 

31 March 2021 

 

Audited

31 December 2020

£ millions

Quoted Investments

0.6

0.2

Unquoted Investments

7.5

10.1

Funds

12.7

11.9

Subtotal Investment portfolio

20.8

22.2

Cash

21.5

20.6

Dacian Investment - Funds Deposited

6.6

6.6

Other Net Assets/Liabilities 

(1.4)

(1.5)

Net Asset Value

47.5

47.9

 

 

NAV at the end of March is based on the valuation of the Company's investments as at 31 December 2020, adjusted for transactions in the three months ended 31 March 2021, price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds, and the latest information available from third party fund managers.

 

Portfolio Unrealised Net Gains

 

The portfolio net unrealised gains of £0.3 million, excluding foreign exchange movements, are summarised below:

 

Quoted Investments

 

The Company's quoted investment valuations increased by a net £0.4 million during the first quarter of 2021, reflecting underlying market price increases.

 

Unquoted Investments

 

The Company's unquoted investments include assets managed by San Francisco Equity Partners (ICU Eyewear and YesTo) and our direct holdings in Medhost, Elateral and Northbridge Industrial Services plc.

 

Total unquoted investment unrealised losses were £1.1 million. This relates to Medhost where Primus Capital, the lead fund manager on Medhost, reduced its valuation resulting in an unrealised loss of £1.1 million for the first quarter on the Company's holding in Medhost.

 

Funds

 

The Company's fund investments include its holding in Brockton Capital Fund I, Opus Capital Partners ("Opus"), Weber Capital Partners ("Weber") and five other smaller fund interests.

 

Total fund unrealised gains were £1.0 million, primarily from Opus and Weber. The carrying value of the funds is based on the latest available information from the respective fund managers, generally the 31 December 2020 fund valuation reports except for Weber, which is based on 31 March 2021 valuations.

 

Portfolio Realisations

 

Realisations from the portfolio during the quarter were a £1.5 million distribution from ICU Eyewear plus other fund distributions of £0.1 million.

 

Liquidity and Outlook

 

The Company continues to maintain significant cash balances, £21.5 million at 31 March, and remains cautious about the way its liquid resources are deployed. The Company continues to review opportunities with its real estate teams, Cavera and George Capital, and has a pipeline of opportunities for other investments.

 

Dacian

 

Our investment in Dacian, the Romanian oil and gas production company, is in the final stage of its approval process with the Romanian authorities. The Dacian team continues to believe the approval process will conclude satisfactorily. Once the approvals have been obtained and the transaction completes, we will issue updated information on the investment.

 

The information contained in this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon publication of this announcement, this inside information is considered to be in the public domain.

 

29 April 2021

 

For further information please contact:

LMS Capital PLC

Nick Friedlos, Managing Director

0207 935 3555

 

Shore Capital

Robert Finlay

0207 408 4050

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUWSRRABUSUUR
Date   Source Headline
13th May 20263:32 pmRNSResults of 2026 Annual General Meeting
24th Apr 20263:37 pmRNSTR‑1: Notification of Major Holdings
24th Apr 20267:00 amRNSFirst Quarter 2026 Update
17th Apr 20261:09 pmRNSNotice of Annual General Meeting
19th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
17th Feb 202612:37 pmRNSTR‑1: Notification of Major Holdings
16th Feb 20267:00 amRNSCompany Update and Unaudited Net Asset Value
13th Jan 20267:00 amRNSSecond Return of Capital
4th Nov 20257:00 amRNS3rd Quarter Trading Update
8th Oct 20259:30 amRNSChange of Auditor
11th Aug 20257:01 amRNSHalf-year Report
11th Aug 20257:00 amRNSInvestment in Dacian
15th Jul 20253:21 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSStatement re B Share issue
15th May 202510:23 amRNSResult of AGM & GM
14th May 20253:01 pmRNSResult of AGM & GM
14th May 20257:00 amRNSAGM Statement
24th Apr 202510:43 amRNSNotice of GM Broadcast
24th Apr 202510:36 amRNSNotice of GM
22nd Apr 20257:00 amRNS1st Quarter Results
8th Apr 20251:47 pmRNSNotice of AGM Broadcast
8th Apr 20251:34 pmRNSNotice of AGM
28th Mar 20257:00 amRNSFinal Results
17th Mar 20259:07 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSStatement re proposed managed realisation
25th Feb 20251:27 pmRNSHolding(s) in Company
19th Feb 20258:44 amRNSHolding(s) in Company
13th Feb 20257:00 amRNSNet Asset Value(s)
20th Dec 20249:22 amRNSDirector/PDMR Shareholding
13th Nov 20244:32 pmRNSCompany Secretary Change
18th Oct 20247:00 amRNSThird Quarter 2024 Update
5th Sep 20243:49 pmRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSSenior Independent Director Appointment
31st Jul 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSUpdate on Investment
16th May 20244:54 pmRNSResult of AGM and Dividend Declaration
15th May 20247:00 amRNSDirectorate Change
8th May 20249:19 amRNS1st Quarter Results
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.